Abstract:Objective:To explore the thyroid hormone levels of perimenopausal depressed patients with anxious characteristics before and after treatment, and further analyze the relationship of anxious symptoms with thyroid hormone levels.Methods:Perimenopausal depressed patients with Hamilton Depression Scale-24 (HAMD-24) score≥20were recruited, HAMA-14was used to assess anxiety level, and patients with anxious characteristics was defined as HAMA-14score＞7.Health subjects with age and education matched were also recruited.Patients were treated with oral escitalopram for 8weeks and clinical symptoms were assessed at the baseline, 4th and 8th week of treatment.Results:A total of 113patients enrolled finally in the study were divided into anxiety group (81patients, 19cases lost) and without anxiety group (52patients, 15cases lost) , and 40health subjects were recruited.There were significant differences on the serum levels of FT4within the group (F=5.668, P＜0.01) , among three groups (F=4.917, P＜0.01) and group×time interaction effect (F=3.685, P＜0.01) .The serum level of FT4of depressed patients with anxiety symptoms at baseline was significantly higher than those without anxious symptoms (t=3.004, P＜0.01) .The serum level of FT4decreased gradually among depressed patients both with and without anxiety symptoms after the treatment, and there were significant differences on serum level of FT4at each time point in anxiety group (F=14.736, P＜0.001) .There were significant differences on serum level of TSH at baseline among three groups (P=0.003) , and the serum level of TSH was significantly lower in the anxiety group than that in the health group (t=-2.600, P＜0.05) .There was no statistical significance on within-subjects effects and the group×time interaction effect (P＞0.05) .Serum levels of FT4and body mass factor scores were all negatively correlated at baseline, 4th and 8th week of treatment (P＜0.05) .In the anxiety group, there were negative correlation between the serum level of FT4and weight factor of HAMD-14at baseline, 4th and 8th week of treatment (P＜0.05) ;there were positive correlations between the serum level of FT4and total score of HAMA-14, somatic anxiety, mental anxiety at baseline, 4th and 8th week respectively (P＜0.05) .Conclusion:There are significant correlations between anxiety symptoms of perimenopausal depressed patients and the serum level of FT4.It may be a potential way for improving anxiety symptoms to regulate thyroid hormone levels.

The changes of thyroid hormone level in readmission patients with depressive disorder

The effect of thyroid function on the risk of psychiatric readmission after hospitalization for major depressive disorder

[Study on Anxiety and Depressive Disorder of Inpatients in General Hospital].

The research about changes of thyroid function in patients with depression

Study on the changes of thyroid hormone levels in patients with perimenopausal depressive episode

The Impact of Quetiapine Monotherapy or in Combination with Lithium on the Thyroid Function in Patients with Bipolar Depression: A Retrospective Study

Comparison of Hair Thyroid Hormones Between First‐episode and Recurrent Patients with Depression in Female Chinese

Comparison of the level of thyroid hormones between patients with major depressive disorder and dysthymic disorder

Study on the level of free thyroxin in first-episode depressions with varied severity

Hair thyroid hormones concentration in patients with depression changes with disease episodes in female Chinese

Comparison of Thyroid Hormone Levels Between Patients With Major Depressive Disorder and Healthy Individuals in China

Changes of peripheral blood cell measurements in patients with subclinical hypothyroidism

Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: A machine learning analysis of the real-world based study.

The Relevant Research of Thyroid Hormones and Clinical Features in Treatment-Resistant Depression

Thyroid hormone levels before and after treatment of perimenopausal depressed patients

Dynamic Risk Factors of Psychiatric Readmission for Major Depressive Disorder: A Longitudinal Study on Patients Treated with Mono-Antidepressant

Changes and its significance of serum thyroid hormone levels in mood disorder patients with the first manic episode

Changes in thyroid function levels in female patients with first-episode bipolar disorder

The effect of neuroendocrine abnormalities on the risk of psychiatric readmission after hospitalization for bipolar disorder: A retrospective study

Change of thyroid hormone in senile patients with coronary heart disease and chronic congestive heart failure

The thyroid hormone level of perimenopausal depressed patients with anxious characteristics